Groups Launch COVID-19 Clinical Trials in Seattle

Human trial will enroll about 100 patients
Updated: Thu, 04/02/2020 - 13:10
 
 
  • Human trial will enroll about 100 patients

Seattle’s Infectious Disease Research Institute is aggressively seeking treatment options for COVID-19.

The institute is partnering with New Jersey-based Celularity Inc. and is launching an immunotherapy study that could be a promising treatment for the virus. The Washington State Department of Health reports that the state has 5,984 confirmed cases as of March 31, with 247 deaths.

The treatment, which just received approval from the Food and Drug Administration, is based on the administration of immune cells known as Natural Killer cells, which have proven effective in early studies in leukemia and multiple myeloma patients.

Those so-called “NK” cells were lower in patients with severe cases of COVID-19.

“To date, efforts to treat COVID-19 cases have been primarily focused on antiviral medications,” says Infectious Disease Research Institute CEO Corey Casper. “While these are important, patients with serious disease may not respond completely to antiviral medications because they are experiencing damage already inflicted on the body’s vital organs.”

The Infectious Disease Research Institute is a nonprofit global health organization founded in 1993. It has 55 employees and more than 100 partners and collaborators around the globe.

Related Content

Remmie Health's new app to monitor ear, nose and throat symptoms debuts Sept. 30

Remmie Health's new app to monitor ear, nose and throat symptoms debuts Sept. 30

If the pilot is successful, it could lead to Zoom+Care offering coronavirus self-testing kits to patients across the Pacific Northwest

The effort is aimed at decoding the human-immune response to the coronavirus and sharing results with researchers and public-health experts globally

The effort is aimed at decoding the human-immune response to the coronavirus and sharing results with researchers globally

The new online health care service also will offer free coronavirus-risk assessments for patients in Washington and Oregon

The new online health care service also will offer free coronavirus-risk assessments for patients in Washington and Oregon